ArticleThe New England journal of medicine2014
Mutant ADA2 in vasculopathies.
Article in The New England journal of medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A wide spectrum of phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review.Orphanet journal of rare diseases · 2023Pooled it
- Mediterranean fever gene variants modify clinical phenotypes of idiopathic multi-centric Castleman disease.Clinical and experimental immunology · 2021Trial
- Review
- Vasculitis and vasculopathy associated with inborn errors of immunity: an overview.Frontiers in pediatrics · 2023Review
- Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies.The Journal of allergy and clinical immunology · 2022Review
- Candidate biomarkers for idiopathic multicentric Castleman disease.Journal of clinical and experimental hematopathology : JCEH · 2022Article
- Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.Frontiers in immunology · 2022Review
- Adult-onset deficiency of adenosine deaminase 2-a case report and literature review.Clinical rheumatology · 2021Review
- Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.Clinical rheumatology · 2021Review
- A Chinese DADA2 patient: report of two novel mutations and successful HSCT.Immunogenetics · 2019Article
- Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic Disease.Frontiers in immunology · 2019Review
- Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease.Hematology. American Society of Hematology. Education Program · 2018Review
- Review
- Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.Rheumatology international · 2018Article
- Vasculitis Pathogenesis: Can We Talk About Precision Medicine?Frontiers in immunology · 2018Review
- Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.Current rheumatology reports · 2017Review
- Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases.Rheumatic diseases clinics of North America · 2017Review
- Early-onset stroke, polyarteritis nodosa (PAN), and livedo racemosa.Journal of the American Academy of Dermatology · 2016Article
- Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency.Journal of clinical immunology · 2016Article
- Update on genetics and pathogenesis of autoinflammatory diseases: the last 2 years.Seminars in immunopathology · 2015Review
Corrections and comments
- Commented on by
- Commented on by
- Comment on
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
25075846What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.